Literature DB >> 27400317

Over-expansion capacity and stent design model: An update with contemporary DES platforms.

Jaryl Ng1, Nicolas Foin2, Hui Ying Ang1, Jiang Ming Fam1, Sayan Sen3, Sukhjinder Nijjer3, Ricardo Petraco3, Carlo Di Mario4, Justin Davies3, Philip Wong1.   

Abstract

BACKGROUND: Previously, we examined the difference in stent designs across different sizes for six widely used Drug Eluting Stents (DESs). Although stent post-dilatation to larger diameter is commonly done, typically in the setting of long tapering segment or left-main PCI, there is an increasing recognition that information with regard to the different stent model designs has a critical impact on overexpansion results. This study aims to provide an update on stent model designs for contemporary DES platforms as well as test overexpansion results under with oversized post-dilatation. METHODS AND
RESULTS: We studied 6 different contemporary commercially available DES platforms: Synergy, Xience Xpedition, Ultimaster, Orsiro, Resolute Onyx and Biomatrix Alpha. We investigated for each platform the difference in stent designs across different sizes and results obtained after post-expansion with larger balloon sizes. The stents were deployed at nominal diameter and subsequently over expanded using increasingly large post dilatation balloon sizes (4.0, 5.0 and 6.0mm at 14ATM). Light microscopy was used to measure the changes in stent geometry and lumen diameter after over-expansion. For each respective DES platform, the MLD observed after overexpansion of the largest stent size available with a 6.0mm balloon was 5.7mm for Synergy, 5.6mm for Xience, 5.2mm for Orsiro, 5.8mm for Ultimaster, 5.5mm for 4mm Onyx (5.9mm for the 5mm XL size) and 5.8mm for BioMatrix Chroma.
CONCLUSION: This update presents valuable novel insights that may be helpful for careful selection of stent size for contemporary DES based on model designs. Such information is especially critical in left main bifurcation stenosis treatment where overexpansion to larger oversized diameter may be required to ensure full stent apposition.
Copyright © 2016 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  DES; Expansion; Left main; Stent

Mesh:

Year:  2016        PMID: 27400317     DOI: 10.1016/j.ijcard.2016.06.097

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

1.  Over-expansion of drug-eluting stents in patients with left main coronary artery disease: An in vivo study.

Authors:  Yicong Ye; Hao Qian; Ming Yang; Xueqing Zhu; Tianpeng Gan; Shuyang Zhang; Yong Zeng
Journal:  J Int Med Res       Date:  2017-06-12       Impact factor: 1.671

2.  Successful Drug-Eluting Stent Overexpansion with Intravascular Ultrasound Guidance for Left Main Bifurcation Lesion Via Left Snuffbox Approach.

Authors:  Yongcheol Kim; Myung Ho Jeong; Min Chul Kim; Doo Sun Sim; Young Joon Hong; Ju Han Kim; Youngkeun Ahn
Journal:  Chonnam Med J       Date:  2019-01-25

3.  Contemporary approaches to bifurcation stenting.

Authors:  Claire E Raphael; Peter D O'Kane
Journal:  JRSM Cardiovasc Dis       Date:  2021-02-24

Review 4.  Fundamentals of percutaneous coronary bifurcation interventions.

Authors:  Tamer Kırat
Journal:  World J Cardiol       Date:  2022-03-26

Review 5.  Long and short of optimal stent design.

Authors:  Timothy Watson; Mark W I Webster; John A Ormiston; Peter N Ruygrok; James T Stewart
Journal:  Open Heart       Date:  2017-10-30

6.  Comparison of overexpansion capabilities and thrombogenicity at the side branch ostia after implantation of four different drug eluting stents.

Authors:  Pawel Gasior; Shengjie Lu; Chen Koon Jaryl Ng; Wee Yee Daniel Toong; En Hou Philip Wong; Nicolas Foin; Elvin Kedhi; Wojciech Wojakowski; Hui Ying Ang
Journal:  Sci Rep       Date:  2020-11-27       Impact factor: 4.379

7.  Elastic stent recoil in coronary total occlusions: Comparison of durable-polymer zotarolimus eluting stent and ultrathin strut bioabsorbable-polymer sirolimus eluting stent.

Authors:  Riccardo Improta; Paola Scarparo; Jeroen Wilschut; Quinten Wolff; Joost Daemen; Wijnand K Den Dekker; Felix Zijlstra; Nicolas M Van Mieghem; Roberto Diletti
Journal:  Catheter Cardiovasc Interv       Date:  2021-05-07       Impact factor: 2.585

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.